2011 Fiscal Year Final Research Report
Development of Alzheimer's disease therapeutics mediate for enhancement of synaptic transmission
Project/Area Number |
22790509
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Applied pharmacology
|
Research Institution | Tohoku University |
Principal Investigator |
|
Project Period (FY) |
2010 – 2011
|
Keywords | sunifiram / LTP / CaMキナーゼII / NMDA受容体グリシン結合部位 / OBXマウス / 電気生理学 / PKC / 認知機能 |
Research Abstract |
Sunifiram is a new pyrrolidone nootropic drug structurally related to piracetam, being development for neurodegenerative disorder like Alzheimer's disease. Sunifiram modulates glycine binding site of NMDAR concomitant increased PKC・activity through Src family kinase. Enhancement of PKC・activity triggered to potentiates hippocampal LTP through activation of CaMKII.
|
Research Products
(16 results)
-
-
-
-
-
[Journal Article] Reduced expression of the ATRX gene, a chromatin-remodeling factor2011
Author(s)
Tatsuya Nogami, Hideyuki Beppu, Takashi Tokoro, Shigeki Moriguchi, Norifumi Shioda, Kohji Fukunaga, Toshihisa Ohtsuka, Yoko Ishii, Masakiyo Sasahara, Yutaka Shimada, Hisao Nishijo, En Li and Isao Kitajima
-
Journal Title
causes hippocampal dysfunction in mice
Volume: 21
Pages: 678-687
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-